Citigroup Inc Taro Pharmaceutical Industries LTD Transaction History

Citigroup Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$40.97 - $43.33 $14,380 - $15,208	351 Added 29.6%	1,537 $65,000
Q4 2023 Feb 09, 2024	BUY	$32.77 - $42.31 $38,373 - $49,545	1,171 Added 7806.67%	1,186 $49,000
Q3 2023 Nov 09, 2023	SELL	$35.46 - $40.13 $88,259 - $99,883	-2,489 Reduced 99.4%	15 $0
Q2 2023 Aug 10, 2023	BUY	$24.24 - $40.97 $59,169 - $100,007	2,441 Added 3874.6%	2,504 $94,000
Q1 2022 May 12, 2022	BUY	$43.12 - $50.3 $2,716 - $3,168	63 New	63 $3,000
Q4 2021 Feb 10, 2022	SELL	$47.6 - $65.0 $212,914 - $290,745	-4,473 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$62.34 - $73.38 $278,846 - $328,228	4,473 New	4,473 $285,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.